Abstract

Progressive degeneration of neuroretinal tissue with maintained elevated intraocular pressure (IOP) to simulate chronic glaucoma was produced by intracameral injections of poly (lactic-co-glycolic) acid (PLGA) microspheres (Ms) in rat eyes. The right eye of 39 rats received different sizes of PLGA-Ms (2 µL suspension; 10% w/v): 14 with 38–20 µm Ms (Ms38/20 model) and 25 with 20–10 µm particles (Ms20/10 model). This novel glaucoma animal model was compared to the episcleral vein sclerosis (EPI) model (25 eyes). Injections were performed at baseline, two, four and six weeks. Clinical signs, IOP, retina and optic nerve thicknesses (using in vivo optical coherence tomography; OCT), and histological studies were performed. An IOP increment was observed in all three groups, however, the values obtained from the PLGA-Ms injection resulted lower with a better preservation of the ocular surface. In fact, the injection of Ms20/10 created a gentler, more progressive, and more sustained increase in IOP. This IOP alteration was correlated with a significant decrease in most OCT parameters and in histological ganglion-cell count for the three conditions throughout the eight-week follow-up. In all cases, progressive degeneration of the retina, retinal ganglion cells and optic nerve, simulating chronic glaucoma, was detected by OCT and corroborated by histological study. Results showed an alternative glaucoma model to the well-known episcleral vein model, which was simpler to perform, more reproducible and easier to monitor in vivo.

Highlights

  • Glaucoma is a degenerative optic neuropathy in which irreversible vision loss is produced by the gradual death of retinal ganglion cells (RGC)

  • This paper presents a new chronic animal glaucoma model created with repeated injections of biodegradable nonloaded poly (lacticco-glycolic) acid (PLGA) Ms into the anterior chamber of rat eyes

  • 38–20 μm size range, while the 20–10 μm fraction resulted in a production yield (PY) of 39.37 ± 1.75%

Read more

Summary

Introduction

Glaucoma is a degenerative optic neuropathy in which irreversible vision loss is produced by the gradual death of retinal ganglion cells (RGC). The mechanism by which elevated IOP leads to RGC death remains unclear. Either laser, cauterization, ligature and/or episcleral vein sclerosis or mechanical blockage of the trabecular meshwork with obstructive substances (hyaluronic acid or paramagnetic, latex or polystyrene beads injected into the anterior chamber) have been used [5]. All these models produce a sudden, short increase in IOP resulting in limited RGC and axonal damage. Studies using non-biodegradable beads to create glaucoma animal models include a wide range of particle sizes, concentrations of administered suspensions and injection frequencies [6,7,8,9,10,11,12,13]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call